Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Gray but Happy: Cardiologists Report High Career Satisfaction, With Some Red Flags for Women

Shelley Wood

December 21, 2016

News Daily News

社会经济地位可能会影响男性他汀类药物的依从性，女性结果不明

Yael L. Maxwell

October 25, 2016

News Daily News

Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women

Yael L. Maxwell

October 25, 2016

News Daily News

La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres

Yael L. Maxwell

October 25, 2016

News Features

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Michael O'Riordan

October 05, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Conference News ACC 2016

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

L.A. McKeown

April 03, 2016

Presentation

Sex Differences in Stable Outpatients With Suspected CAD

Presenter: Kshipra Hemal

April 03, 2016

News Daily News

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

Caitlin E. Cox

February 28, 2016

News Daily News

Los Cuidados Subóptimos de Mujeres con EAC se asocian a una Mayor Mortalidad a Largo Plazo

Caitlin E. Cox

February 28, 2016

News Daily News

CAD 女性患者护理水平不够理想与长期死亡率较高相关

Caitlin E. Cox

February 28, 2016

News Daily News

Undisclosed Clinical Trial Results Across All Major Academic Medical Centers: “A Failed Moral Obligation”

Michael O'Riordan

February 17, 2016

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Biotronik launches CRT in women study

July 08, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Gray but Happy: Cardiologists Report High Career Satisfaction, With Some Red Flags for Women

社会经济地位可能会影响男性他汀类药物的依从性，女性结果不明

Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women

La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

Sex Differences in Stable Outpatients With Suspected CAD

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

Los Cuidados Subóptimos de Mujeres con EAC se asocian a una Mayor Mortalidad a Largo Plazo

CAD 女性患者护理水平不够理想与长期死亡率较高相关

Undisclosed Clinical Trial Results Across All Major Academic Medical Centers: “A Failed Moral Obligation”

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Biotronik launches CRT in women study

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content